Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Efficacy of Tiotropium Respimat vs HandiHaler in COPD
NCT01222533Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01222533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222533.